LIVER TRANSPLANTATION AND HBV INFECTION

LIVER TRANSPLANTATION AND HBV INFECTION

The paper describes the modern approaches in treatment of hepatitis B virus (HBV)-infected patients who underwent liver transplantation. The patients with HBV liver cirrhosis and waiting for orthotopic liver transplantation (OLT) have to receive long-term therapy with nucleos(t)ide analogs right up...

Full description

Bibliographic Details
Main Authors:	O. I. Andreytseva, A. V. Kozlova, V. E. Sutkin
Format:	Article
Language:	Russian
Published:	Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2009-06-01
Series:	Вестник трансплантологии и искусственных органов
Subjects:	liver transplantation recurrent hbv infection de novo hepatitis b immunoglobulin against hbv (hbig) lamivudine entecavir
Online Access:	https://journal.transpl.ru/vtio/article/view/278

Similar Items

HBV-INFECTION DE NOVO AFTER ORTHOTOPIC LIVER TRANSPLANTATION: CLINICAL AND VIROLOGICAL CHARACTERISTICS, ASSESSMENT OF ANTIVIRUS THERAPY EFFECTIVENESS
by: O. I. Malomuzh, et al.
Published: (2012-09-01)

Post-liver transplant HBV infection (Review)
by: A. D. Nikogosova, et al.
Published: (2022-07-01)

<i>De novo</i> hepatitis B virus infection after liver transplantation
by: A. D. Nikogosova, et al.
Published: (2022-09-01)

Liver transplantation for HBV-related liver disease: Impact of prophylaxis for HBV on HCC recurrence
by: Patrizia Burra, et al.
Published: (2025-03-01)

Treatments of Hepatocellular Carcinoma Patients with Hepatitis B Virus Infection: Treat HBV-related HCC
by: Charing Ching-Ning Chong, et al.
Published: (2016-03-01)

DIFFERENT COURSES OF HBV INFECTION AFTER LIVER TRANSPLANTATION
by: V. E. Syutkin, et al.
Published: (2011-06-01)

PEMBERIAN IMUNISASI HEPATITIS B (PASIF) PADA BAYI YANG LAHIR DARI IBU HBsAg POSITIF
by: Ramadhani A. K. S, et al.
Published: (2021-06-01)

Lamivudine for chronic hepatitis B: a brief review
by: Emilio Palumbo

A Sleeping Giant: Late HBV Reactivation After Rituximab-Based Chemotherapy Despite Correct Prophylaxis
by: Nowicka AA, et al.
Published: (2024-12-01)

Predictive factors for response to Lamivudine in chronic hepatitis B
by: Luiz Caetano da SILVA, et al.
Published: (2000-08-01)

The Role of Antiviral Prophylaxis in Preventing HBV and HDV Recurrence in the Setting of Liver Transplantation
by: Sara Battistella, et al.
Published: (2023-04-01)

Prognostic value of plasma level of superoxide dismutase in HBV-related acute-on-chronic liver failure
by: Naijuan Yao, et al.
Published: (2022-06-01)

Human polyclonal anti-hepatitis B surface antigen immunoglobulin reduces the frequency of acute rejection after liver transplantation for chronic hepatitis B
by: Claudia Alves COUTO, et al.
Published: (2001-12-01)

Severe Acute Hepatitis B Treated with Entecavir
by: Giuseppe Vittorio Luigi De Socio, et al.
Published: (2011-03-01)

Severe Acute Hepatitis B Treated with Entecavir
by: Andrea Tosti, et al.
Published: (2011-01-01)

HBV Reactivation in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Narrative Review
by: Giuseppe Gentile, et al.
Published: (2019-11-01)

Discontinuation of Passive Immunization Is Safe after Liver Transplantation for Combined HBV/HDV Infection
by: Ramin Raul Ossami Saidy, et al.
Published: (2021-05-01)

Hepatitis B virus-infection related cryoglobulinemic vasculitis. Clinical manifestations and the effect of antiviral therapy: A review of the literature
by: Cesare Mazzaro, et al.
Published: (2023-02-01)

Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis
by: Aoran Luo, et al.
Published: (2018-09-01)

Efficacy of hepatitis B vaccination in patients awaiting liver transplantation in prophylaxis of <i>de novo</i> HBV-infection of a graft
by: V. Ye. Syutkin, et al.
Published: (2010-04-01)

Occult hepatitis B virus infection in liver transplant patients in a Brazilian referral center
by: T.C.A. Ferrari, et al.
Published: (2014-11-01)

Editorial: HBV and lymphoma
by: Giuseppe Gentile, et al.
Published: (2023-07-01)

HBV Infection Status Indicates Different Risks of Synchronous and Metachronous Liver Metastasis in Colorectal Cancer: A Retrospective Study of 3132 Patients with a 5-Year Follow-Up
by: Zhou J, et al.
Published: (2022-04-01)

Comparative Efficacy of Etiotropic Therapy of Patients with HBeAg-Positive Chronic Hepatitis B (by the Data of the International Comparative Placebo-Controlled Study)
by: V. V. Stelmakh, et al.
Published: (2020-05-01)

Mutational Analysis of HBs Ag-Positive Mothers and Their Infected Children despite Immunoprophylaxis
by: Azam Ghaziasadi, et al.
Published: (2013-12-01)

Antiviral therapy against chronic hepatitis B in Brazil: high rates of lamivudine resistance mutations and correlation with HBV genotypes
by: Francisco Campello do Amaral Mello, et al.
Published: (2012-05-01)

Effect of S-region mutations on HBsAg in HBsAg-negative HBV-infected patients
by: Hui Liu, et al.
Published: (2024-04-01)

Increasing Prevalence of Occult HBV Infection in Adults Vaccinated Against Hepatitis B at Birth
by: Ge Zhong, et al.
Published: (2025-02-01)

Early intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxis
by: François Villeret, et al.
Published: (2023-06-01)

Quasispecies and Pre-Existing Drug-Resistant Mutations of Hepatitis B Virus in Patients with Chronic Hepatitis B
Published: (2013-05-01)

Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B
by: Kwan Sik Lee, et al.
Published: (2017-12-01)

HBV-RNA, Quantitative HBsAg, Levels of HBV in Peripheral Lymphocytes and HBV Mutation Profiles in Chronic Hepatitis B
by: Yael Gozlan, et al.
Published: (2022-03-01)

The Levels of Serum HBV Pre-Genomic RNA and Its Associated Factors Among HBV-Infected Patients: A Retrospective Cohort Study in Hangzhou, Zhejiang, China
by: Zuo Z, et al.
Published: (2024-10-01)

Risk of occupational exposure to the HBV infection in non-clinical healthcare personnel
by: Weronika Rymer, et al.
Published: (2016-06-01)

NAFLD and HBV interplay - related mechanisms underlying liver disease progression
by: Evanthia Tourkochristou, et al.
Published: (2022-12-01)

HBV - infection in children with perinatal infection. Clinical report of familial hepatitis B
by: I. V. Shilova, et al.
Published: (2021-10-01)

Lamivudine and Entecavir for Acute Hepatitis B: A Systematic Review and Meta-Analysis
by: Cesar Henriquez-Camacho, et al.
Published: (2023-11-01)

Off-treatment efficacy of 3-year nucleos(t)ide analogues in chronic hepatitis B patients
by: Ching-Chung Lin, et al.
Published: (2016-01-01)

The Hepatitis B Surface Antigen Binding Protein: An Immunoglobulin G Constant Region-Like Protein That Interacts With HBV Envelop Proteins and Mediates HBV Entry
by: Yeping Sun, et al.
Published: (2018-09-01)

Prevalence of occult hepatitis B virus infection in kidney transplant recipients
by: Cibele Franz, et al.
Published: (2013-08-01)